Dermacyd Femina (Lactic Acid) Pocket BR - Photo Evaluation
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00783640 |
Recruitment Status :
Completed
First Posted : November 3, 2008
Last Update Posted : December 19, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Hygiene | Drug: Lactic Acid | Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 27 participants |
Allocation: | Non-Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd Femina Pocket BR. |
Study Start Date : | October 2008 |
Actual Primary Completion Date : | November 2008 |

Arm | Intervention/treatment |
---|---|
Experimental: 1
Lactic Acid
|
Drug: Lactic Acid
Drug: Lactic Acid (Dermacyd Femina) |
- The photo irritation test and the photosensitivity will be measured using UVA irradiation and evaluated according International Contact Dermatitis Research Group (ICDRG) scale. [ Time Frame: Throughout the study ]
- The sensibility will be evaluated according to the skin type. [ Time Frame: Throughout the study ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion criteria:
- Age between 18 and 60 years old;
- Phototype Skin I,II, III e IV
- Integral skin test in the region;
- Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion;
Exclusion criteria:
- Lactation or gestation
- Use of Antiinflammatory and/or immunosuppression drugs one month before the study;
- Personnel history of atopy;
- History of sensitivity or irritation for topic products;
- Active cutaneous disease;
- Use of new drugs or cosmetics during the study;
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00783640
Brazil | |
Sanofi-Aventis Administrative Office | |
Sao Paulo, Brazil |
Study Director: | Jaderson Lima | Sanofi |
Additional Information:
Responsible Party: | Medical Affairs Study Director, sanofi-aventis |
ClinicalTrials.gov Identifier: | NCT00783640 History of Changes |
Other Study ID Numbers: |
LACAC_L_04371 |
First Posted: | November 3, 2008 Key Record Dates |
Last Update Posted: | December 19, 2008 |
Last Verified: | December 2008 |